LIGHT (TNFSF14/CD258) Is a Decisive Factor for Recovery from Experimental Autoimmune Encephalomyelitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LIGHT (TNFSF14/CD258) Is a Decisive Factor for Recovery from Experimental Autoimmune Encephalomyelitis

Published:2013-05-29 Issue:1 Volume:191 Page:154-163
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Maña Paula,Liñares David,Silva Diego G.,Fordham Susan,Scheu Stefanie,Pfeffer Klaus,Staykova Maria,Bertram Edward M.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference57 articles.

1. LIGHT, a New Member of the TNF Superfamily, and Lymphotoxin α Are Ligands for Herpesvirus Entry Mediator

2. Herpesvirus Entry Mediator Ligand (HVEM-L), a Novel Ligand for HVEM/TR2, Stimulates Proliferation of T Cells and Inhibits HT29 Cell Growth

3. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer.

4. LIGHT, a TNF-Like Molecule, Costimulates T Cell Proliferation and Is Required for Dendritic Cell-Mediated Allogeneic T Cell Response

5. A Newly Identified Member of the Tumor Necrosis Factor Receptor Superfamily with a Wide Tissue Distribution and Involvement in Lymphocyte Activation

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunobiology of lymphotoxin: role in a mouse model of multiple sclerosis;Russian Journal of Immunology;2023-09-22

2. Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes;Nature Communications;2022-11-28

3. Serological biomarkers in autoimmune GFAP astrocytopathy;Frontiers in Immunology;2022-08-02

4. Low-dose IL-2 reduces IL-21⁺T cells and induces a long-lived anti-inflammatory gene expression signature inversely modulated in COVID-19 patients;2022-04-05

5. HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160;Journal of Experimental Medicine;2021-10-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3